ADS051, AN ORAL, GUT-RESTRICTED, SMALL MOLECULE NEUTROPHIL MODULATOR IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS RECEIVING MULTIPLE ASCENDING DOSES
Jessica Allegretti 1
Adam S. Cheifetz 2, 3
Parambir S. Dulai 4
A. C. Stevens 5
Jillian Chapas-Reed 6
Laurent Chesnel 6
Bharat Dixit 6
Ronald Farquhar 6
Parviz Ghahramani 7
Benjamin Miller 6
Christopher Murphy 6
Megan Quintas 6
Raisa Tanase 8
Tengiz Telia 9
Barbara Wozniak-Stolarska 10
Renu Gupta 6
1 Brigham and Women's Hospital Division of Gastroenterology, Cambridge, United States
2 Beth Israel Deaconess Medical Center, Boston, United States
3 Harvard Medical School, Boston, United States
4 Northwestern University Feinberg School of Medicine, Chicago, United States
5 Independent Biopharmaceutical Consultant, Boston, United States
6 Adiso Therapeutics, Inc., Concord, United States
7 Inncelerex, Jersey City, United States
8 ARENSIA Exploratory Medicine, Republican Clinical Hospital, Chisinau, Moldova, Republic of
9 ARENSIA Exploratory Medicine LLC, Tbilisi, Georgia
10 PlanetMed Gastroenterology Sp. z o.o., Wroclaw, Poland
Topic
Colorectal
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]